KINGFA NSE filing

Kingfa India reports increased Q2 & H1 FY26 standalone profit, approves board committee changes

The RealCase readMedium impact Positive

Kingfa India reported increased standalone revenue and net profit for the quarter and half-year ended September 30, 2025. The Board also approved changes to committee compositions and the RPT Policy.

Why it matters

The announcement includes positive quarterly financial results, which are a key indicator for investors, alongside important governance updates like changes in board committees and amendments to the RPT policy, which are significant for operations and compliance.

The market read

The company reported increased standalone revenue and net profit on a year-on-year basis for both the quarter and half-year ended September 30, 2025, indicating strong financial performance. Changes to board committees and RPT policy are governance-related and generally neutral.

* The Board of Directors of Kingfa Science & Technology (India) Limited, in a meeting held on November 12, 2025, approved the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2025. * For the quarter ended September 30, 2025: * Revenue from Operations stood at ₹46,568.91 lakh. * Net Profit for the period was ₹4,114.38 lakh. * Basic Earnings Per Share (EPS) was ₹30.36. * For the half year ended September 30, 2025: * Revenue from Operations was ₹92,762.34 lakh. * Net Profit for the period was ₹8,093.48 lakh. * Basic Earnings Per Share (EPS) was ₹59.72. * The Board also approved changes in the composition of certain Board Committees. The revised committees include the Audit Committee (no change), Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee (no change), and Corporate Social Responsibility Committee. * Additionally, the Board approved an amendment to the Company’s Policy on Related Party Transactions (RPT Policy) to align with recent amendments to Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and industry standards on minimum information for RPT approvals. The revised policy is effective immediately and available on the company's website.

Filing to action

What to do with a filing like this

Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.

View original filing